AKT1 and colorectal carcinoma: Based on in vitro and in vivo results, RP4 directly inhibited the growth and metastasis of CRC cell lines, including HCT116, LoVo, and CT26, through blocking the AKT and Wnt/β-catenin signaling pathways.